Acute Dystonia, Akathisia, and Parkinsonism Induced by Ziprasidone
Samir Kumar Praharaj, Amlan Kusum Jana, Sujit Sarkhel, Vinod Kumar Sinha
Abstract
Samir Kumar Praharaj, Amlan Kusum Jana, Sujit Sarkhel, Vinod Kumar Sinha
Abstract
Ziprasidone is a second-generation antipsychotic with a lower propensity to cause extrapyramidal adverse effects that are seen at higher doses. We report a patient who developed acute dystonia, parkinsonism, and severe akathisia with ziprasidone 80 mg/d. These adverse effects subsided after dose reduction and specific treatment for akathisia and parkinsonism.
OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Ziprasidone is a second-generation antipsychotic with a lower propensity to cause extrapyramidal adverse effects that are seen at higher doses. We report a patient who developed acute dystonia, parkinsonism, and severe akathisia with ziprasidone 80 mg/d. These adverse effects subsided after dose reduction and specific treatment for akathisia and parkinsonism.
Key concepts: Akathisia, Ziprasidone, Parkinsonism, Dystonia, Medicine, Extrapyramidal symptoms, Antipsychotic, Adverse effect